Clinical trial registry record

A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated July 3, 2023.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05135195
Last registry update
July 3, 2023
Status
Completed
Phase
Phase not reported
Sponsor
NYU Langone Health
Enrollment
98
Countries
United States
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NON RANDOMIZED · PARALLEL · SCREENING · NONE
Evidence population
Human clinical study registration
Participants
98
Population
ALL · 18 Years to 80 Years
Duration
2021-10-24 to 2022-10-20
Intervention
In-House Developed VR Platform - AMD, DR, Glaucoma; In-House Developed VR Platform - Glaucoma
Comparator
Not reported
Outcomes measured
Average time to complete the trial — 1 Day of Intervention; Average number of obstacle collisions during the trial — 1 Day of Intervention; Average travel time — 1 Day of Intervention; Average distance traveled by the participant — 1 Day of Intervention; Preferred walking speed — 1 Day of Intervention; Orientation — 1 Day of Intervention; Number of instances in which the participant stop for more than 2 seconds — 1 Day of Intervention; Total time spent during stops of more than 2 seconds — 1 Day of Intervention; Average time it takes to understand how to interact with the system and run the simulation of the bus ride — 1 Day of I…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Vision ageing · 100%Abstract contains controlled term: age-related macular degeneration. Source terminology contains: age-related macular degeneration. Abstract supplies longevity context: age-related. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

vision aging
Open primary sourceExport JSON